US 9,890,141 · Application 15/144,892 · Granted Feb 13, 2018
US 9,890,141
Crystalline pharmaceutical and methods of preparation and use thereof
Estimated expiration
October 21, 2030
4y 24d remaining
Earliest effective filing
Oct 21, 2010
+ 20 years
Oct 21, 2030
PTA +0d
Oct 21, 2030
TD cap (US 9,353,088)
Oct 21, 2030
Final
Oct 21, 2030
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- May 3, 2016
- Earliest effective filing
- October 21, 2010
- Issue date
- February 13, 2018
- PTA
- 0 days
- Base expiry (before PTA)
- October 21, 2030
October 21, 2010 + 20 years = October 21, 2030
- Continuation of application 14/556,715, filed Dec 1, 2014, issued as US 9,353,088
- Continuation of application 13/713,238, filed Dec 13, 2012, issued as US 8,927,574
- Continuation of application 12/909,241, filed Oct 21, 2010, issued as US 8,378,105
- Continuation of application 12/909,241, filed Oct 21, 2010, issued as US 8,378,105
- Continuation of application 13/713,238, filed Dec 13, 2012, issued as US 8,927,574
- Continuation of application 12/909,241, filed Oct 21, 2010, issued as US 8,378,105
- PRO61/253,828 — Provisional — not used for base term
- PRO61/253,828 — Provisional — not used for base term
- PRO61/253,828 — Provisional — not used for base term
- PRO61/253,828 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to October 21, 2030 (earliest expiring referenced patent: US 9,353,088)
US 8,378,105· Application 12/909,241Capping patent
Crystalline pharmaceutical and methods of preparation and use thereof
- Filing date
- Oct 21, 2010
- Earliest effective filing
- Oct 21, 2010
- Issue date
- Feb 19, 2013
- PTA
- +139 days
- Calculated expiration
- Mar 9, 2031
Oct 21, 2010 + 20y + 139d PTA = Mar 9, 2031
US 9,353,088· Application 14/556,715Capping patent
Crystalline pharmaceutical and methods of preparation and use thereof
- Filing date
- Dec 1, 2014
- Earliest effective filing
- Oct 21, 2010
- Issue date
- May 31, 2016
- PTA
- 0 days
- Calculated expiration
- Oct 21, 2030
Continuation of 13/713,238, filed Dec 13, 2012, issued as US 8,927,574
Continuation of 12/909,241, filed Oct 21, 2010, issued as US 8,378,105
Continuation of 12/909,241, filed Oct 21, 2010, issued as US 8,378,105
Oct 21, 2010 + 20y = Oct 21, 2030
US 9,890,141· Application 15/144,892(from application 15/144,892)
Crystalline pharmaceutical and methods of preparation and use thereof
- Filing date
- May 3, 2016
- Earliest effective filing
- Oct 21, 2010
- Issue date
- Feb 13, 2018
- PTA
- 0 days
- Calculated expiration
- Oct 21, 2030
Continuation of 14/556,715, filed Dec 1, 2014, issued as US 9,353,088
Continuation of 13/713,238, filed Dec 13, 2012, issued as US 8,927,574
Continuation of 12/909,241, filed Oct 21, 2010, issued as US 8,378,105
Continuation of 12/909,241, filed Oct 21, 2010, issued as US 8,378,105
Continuation of 13/713,238, filed Dec 13, 2012, issued as US 8,927,574
Continuation of 12/909,241, filed Oct 21, 2010, issued as US 8,378,105
Oct 21, 2010 + 20y = Oct 21, 2030
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 15/144,892 · US 9,890,141
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 9,890,141: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US9890141Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.